Qualitative evaluation of a local coronary heart disease treatment pathway: practical implications and theoretical

Lena Kramer1, Kathrin Schlößler, Susanne Träger

  • 1Department of General Practice/Family Medicine, University of Marburg, Karl-von-Frisch-Straße 4, 35043, Marburg, Germany. lena.kramer@staff.uni-marburg.de

BMC Family Practice
|May 16, 2012
PubMed

Insights

A new coronary heart disease (CHD) treatment pathway was positively evaluated by general practitioners (GPs) and cardiologists. Implementation success depends on pathway, behavior, interaction, and system factors, requiring a combined strategy for optimal adaptation.

Area of Science:

  • Cardiology
  • General Practice
  • Health Services Research

Background:

  • Coronary heart disease (CHD) necessitates shared care between general practitioners (GPs) and cardiologists.
  • A local treatment pathway was developed to enhance cooperation for CHD patients.
  • The study aimed to evaluate GP opinions on the pathway and propose a theoretical framework for implementation factors.

Purpose of the Study:

  • Evaluate general practitioners' (GPs) opinions on a new coronary heart disease (CHD) treatment pathway.
  • Identify key factors influencing the pathway's practical implementation.
  • Develop a multi-dimensional theoretical framework for pathway implementation.

Main Methods:

  • Qualitative study using face-to-face interviews with pathway developers (GPs, cardiologists) and users (GPs).
  • Interviews guided by the theory of planned behavior (TPB) and previous studies.
  • Verbatim transcription and qualitative content analysis of interview data.

Main Results:

  • Ten key factors impacting CHD treatment pathway implementation were identified.
  • Factors categorized as pathway-related, behavior-related, interaction-related, and system-related.
  • Pathway evaluation was positive, but clinical behavior change was not automatic; some GPs felt current practice aligned with the pathway.

Conclusions:

  • Study contributes knowledge on factors influencing physicians' adoption of local treatment pathways for CHD.
  • Combined implementation strategies addressing internal and external factors are recommended for better adaptation.
  • A theoretical framework is proposed, categorizing factors across micro (pathway), meso (interaction), and macro (system) levels.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...